Skip to main content
logo
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
37.02
+0.78 (2.15%)
Aug 7, 2026, 4:00 PM EDT - Market closed

IDEAYA Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
234.13218.71723.3950.9327.94
Revenue Growth
3244.67%3024.43%-70.07%-54.09%82.28%43.01%
Gross Profit
234.13218.71723.3950.9327.94
Operating Income
-216.95-159.31-326.98-134.43-62.5-50.27
Net Income
-175.02-113.7-274.48-112.96-58.66-49.76
Earnings Per Share
-1.94-1.28-3.36-1.96-1.42-1.41
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
828.96639.39676.32525.11364.83246.77
Total Debt
29.3127.9119.172.873.485.18
Net Cash (Debt)
799.65611.47657.15522.24361.35241.59
Net Cash Growth
24.34%-6.95%25.83%44.53%49.57%-12.74%
Net Cash Per Share
8.916.918.059.088.726.85

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-111.66-71.1-247.58-115.22-87.18-55.78
Capital Expenditures
-2.21-2.37-3.86-2.37-3.44-2.64
Free Cash Flow
-113.87-73.47-251.44-117.59-90.62-58.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-92.66%-72.84%-4671.07%-574.85%-122.72%-179.91%
Pretax Margin
-74.75%-51.99%-3921.10%-483.05%-115.17%-178.10%
Profit Margin
-74.75%-51.99%-3921.10%-483.05%-115.17%-178.10%
FCF Margin
-48.64%-33.59%-3592.01%-502.85%-177.92%-209.09%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-68.3668.3668.3668.3668.36
PS Ratio
15.2613.88317.5998.9617.1932.60